SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-026498
Filing Date
2024-07-08
Accepted
2024-07-08 17:10:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 375291
2 ex5-1.htm EX-5.1 68804
3 ex23-1.htm EX-23.1 2690
4 ex107.htm EX-FILING FEES 32026
5 forms-3_001.jpg GRAPHIC 5340
6 ex5-1_001.jpg GRAPHIC 7364
7 ex5-1_003.jpg GRAPHIC 13733
8 ex5-1_002.jpg GRAPHIC 9719
  Complete submission text file 0001493152-24-026498.txt   530292
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280721 | Film No.: 241105704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)